Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies

Published on May 21, 2024

Over the last decade, several breakthrough Cell and Gene Therapy products have been approved in the USA and Europe to turn stem cells and immune cells into ‘living cures’, bringing hope to millions living with life-threatening conditions. However, these treatments remain out of reach for 98% of patients suffering from what are now curable conditions….

This content is for members only. Visit the site and log in/register to read.

The post Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies appeared first on EU-Startups.

Continue reading on website
Other news

London-based LabGenius raises over €40.1 million to further develop its ML-driven antibody discovery platform

May 21, 2024
London-based LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, today announced that it has closed a Series B financing round of over €40.1 million. The investment brings LabGenius’ total funding to date to more than €67.8 million. The round was led by new investor M… This content is for members only. Visit the site and log

London-based Zen Educate secures €34 million Series B to connect schools with absent staff to the best available teachers

May 21, 2024
Zen Educate, an online marketplace that matches schools with the best available substitute teachers and teaching assistants, has successfully closed a €34 million Series B. It was led by Round2 Capital, with support from existing investors Adjuvo, Brighteye Ventures, FJ Labs, Ascension Ventures, and prominent angels, including Octopus founder and CEO Simon Rogerson. This marks… This content is for